Работы, на которые ссылается эта работа

Работ: 72

Работа: Neurological complications after covid-19 vaccination

Без названия
ДругоеЦитирований: 8
ABI
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin +26
Статья2020Цитирований: 8
ABI
Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults
Lianpan Dai, Lidong Gao, Lifeng Tao +27
Статья2022Цитирований: 7
ABI
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink +34
Статья2020Цитирований: 6
ABI
Nervous system involvement after infection with COVID-19 and other coronaviruses
Yeshun Wu, Xiaolin Xu, Zijun Chen +5
Обзорная статья2020Цитирований: 5
ABI
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov +28
Статья2021Цитирований: 5
ABI
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Jerald Sadoff, Glenda Gray, An Vandebosch +27
Статья2021Цитирований: 4
ABI
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael +30
Статья2020Цитирований: 3
ABI
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh, Robert W. Frenck, Ann R. Falsey +22
Статья2020Цитирований: 3
ABI
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Tom T. Shimabukuro, Michael Nguyen, David Martin +1
Обзорная статья2015Цитирований: 3
ABI
The spectrum of post-vaccination inflammatory CNS demyelinating syndromes
Dimitrios Karussis, Panayiota Petrou
Обзорная статья2013Цитирований: 3
ABI
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Cristina Menni, Kerstin Kläser, Anna May +25
Статья2021Цитирований: 3
ABI
Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases
Maxime Taquet, Masud Husain, John Geddes +2
Статья2021Цитирований: 3
ABI
Improvements in Gene Therapy
Thomas Ritter, Manfred Lehmann, Hans‐Dieter Volk
Обзорная статья2002Цитирований: 2
ABI
Intravascular adenoviral agents in cancer patients: Lessons from clinical trials
Tony Reid, Robert S. Warren, David H. Kirn
Обзорная статья2002Цитирований: 2
ABI
Quadrivalent HPV Vaccination and Risk of Multiple Sclerosis and Other Demyelinating Diseases of the Central Nervous System
Nikolai Madrid Scheller, Henrik Svanström, Björn Pasternak +4
Статья2015Цитирований: 2
ABI
A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses
Elizabeth S. Gabitzsch, Younong Xu, Lois H. Yoshida +4
Статья2008Цитирований: 2
ABI
The influence of innate and pre‐existing immunity on adenovirus therapy
Anne K. Zaiss, Hidevaldo B. Machado, Harvey R. Herschman
Обзорная статья2009Цитирований: 2
ABI
Epilepsy and vaccinations: Italian guidelines
Dario Pruna, Paolo Balestri, Nelia Zamponi +8
Обзорная статья2013Цитирований: 2
ABI
Under-Reporting of Adverse Drug Reactions
Lorna Hazell, Saad Shakir
Обзорная статья2006Цитирований: 2
ABI
Hemostasis factors and aging
Daniela Mari, Raffaella Coppola, Rita Provenzano
Обзорная статья2007Цитирований: 2
ABI
Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans
Claudio Franceschi, Miriam Capri, Daniela Monti +10
Обзорная статья2006Цитирований: 2
ABI
Liver Toxicities Typically Induced by First-Generation Adenoviral Vectors Can Be Reduced by Use of E1, E2b-Deleted Adenoviral Vectors
Ruth Everett, Bradley L. Hodges, Enyu Ding +3
Статья2003Цитирований: 2
ABI
Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin
Katalin Karikó, Hiromi Muramatsu, Jason M. Keller +1
Статья2012Цитирований: 2
ABI
Live virus vaccines based on a yellow fever vaccine backbone: Standardized template with key considerations for a risk/benefit assessment
Thomas P. Monath, Stephen Seligman, James S. Robertson +7
Обзорная статья2014Цитирований: 2
ABI